Dosage and administration
Place a small amount of Laxatone ® on cat's nose or paws to stimulate taste interest.
Place a small amount of Laxatone ® on cat's nose or paws to stimulate taste interest.
STORE IN A COOL PLACE REMOVE PROTECTIVE FOIL BEFORE USING Lot No & Exp. date on Crimp of Tube
Laxatone® is a veterinarian formulated lubricant that helps eliminate and prevent hairballs with a taste cats love. The #1-selling hairball remover trusted by pet owners worldwide for over 30 years.
Place a small amount of Laxatone® on cat's nose or paws to stimulate taste interest.
White petrolatum USP, light mineral oil NF, corn syrup, malt syrup, soybean oil, cane molasses, water, gelatin by-products, sodium benzoate (preservative), natural and artificial flavors.
For Hairballs - ½ -1 tsp. for 2-3 days, then ¼ - ½ tsp. 2-3 times a week.
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN AND PETS
STORE IN A COOL PLACE
REMOVE PROTECTIVE FOIL BEFORE USING
Lot No & Exp. date on Crimp of Tube
Made in Canada by
Vétoquinol Prolab Inc.
Princeville, Québec, Canada
For Tomlyn Products
Division of Vétoquinol USA, Inc.
Ft. Worth, TX (USA) 76137
www.tomlyn.com
6782
10C
24797D
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Mineral Oil | ACTIVE INGREDIENT | T5L8T28FGP | 2 | |
| Petrolatum | ACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| Mineral Oil | ACTIVE MOIETY | T5L8T28FGP | 2 | |
| Petrolatum | ACTIVE MOIETY | 4T6H12BN9U | 2 | |
| Corn Syrup | INACTIVE INGREDIENT | 9G5L16BK6N | 2 | |
| Gelatin | INACTIVE INGREDIENT | 2G86QN327L | 2 | |
| Maltose Syrup | INACTIVE INGREDIENT | 00JKR0NZ8O | 2 | |
| Molasses | INACTIVE INGREDIENT | LSU3YX0KZO | 2 | |
| Sodium Benzoate | INACTIVE INGREDIENT | OJ245FE5EU | 2 | |
| Soybean Oil | INACTIVE INGREDIENT | 241ATL177A | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 47171-106 | 47171-106-13 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Petrolatum | 4T6H12BN9U | ACTIB |
| Mineral Oil | T5L8T28FGP | ACTIB |
| Corn Syrup | 9G5L16BK6N | IACT |
| Soybean Oil | 241ATL177A | IACT |
| Maltose Syrup | 00JKR0NZ8O | IACT |
| Molasses | LSU3YX0KZO | IACT |
| Gelatin | 2G86QN327L | IACT |
| Sodium Benzoate | OJ245FE5EU | IACT |
| Water | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Gelatin | GELATIN | 2G86QN327L | CAPSULE, DELAYED RELEASE / ORAL | 1791 mg | ||
| Corn Syrup | CORN SYRUP | 9G5L16BK6N | TROCHE / ORAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | SYRUP / ORAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE, EXTENDED RELEASE / ORAL | 1229 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 14 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | 13 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / TOPICAL | 0.1 %w/v | ||
| Gelatin | GELATIN | 2G86QN327L | SOLUTION / INTRAVENOUS | 34.8 mg | ||
| Corn Syrup | CORN SYRUP | 9G5L16BK6N | SYRUP / ORAL | 600 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SYSTEM / TOPICAL | 2 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | PASTE, DENTIFRICE / DENTAL | 0.5 %w/w | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| Soybean Oil | SOYBEAN OIL | 241ATL177A | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 10 %w/v | ||
| Gelatin | GELATIN | 2G86QN327L | PASTE / DENTAL | 252 mg | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Gelatin | GELATIN | 2G86QN327L | WAFER / ORAL | NA | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| Corn Syrup | CORN SYRUP | 9G5L16BK6N | ELIXIR / ORAL | 400 mg/1ml | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / INTRAVENOUS | 20 mg | ||
| Soybean Oil | SOYBEAN OIL | 241ATL177A | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 223 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| Corn Syrup | CORN SYRUP | 9G5L16BK6N | SUSPENSION / ORAL | 2500 mg/5ml | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / SUBCUTANEOUS | 16 %w/v | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | POWDER / RESPIRATORY (INHALATION) | 100 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | FILM / BUCCAL | 1 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | PASTE / DENTAL | 0.08 %w/w | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 1 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION, SOLUTION / INTRAMUSCULAR | 4.8 %w/v | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, CHEWABLE / ORAL | 24 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 2 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / INTRAMUSCULAR | 16 %w/v | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, SUGAR COATED / ORAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | GUM, CHEWING / BUCCAL | 102 mg | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE, COATED PELLETS / ORAL | 65 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, EXTENDED RELEASE / ORAL | 239 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, DELAYED RELEASE / ORAL | 19 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | GEL / DENTAL | 0.08 %w/w | ||
| Gelatin | GELATIN | 2G86QN327L | SOLUTION / ORAL | 34.8 mg | ||
| Gelatin | GELATIN | 2G86QN327L | ELIXIR / ORAL | NA | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAMUSCULAR | 864 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | 160 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | 120 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 14 mg | ||
| Corn Syrup | CORN SYRUP | 9G5L16BK6N | TROCHE / BUCCAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET / ORAL | 46 mg | ||
| Soybean Oil | SOYBEAN OIL | 241ATL177A | INJECTION / INTRAVENOUS | 10 %w/v | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / INTRACAVITARY | 0.05 ml | ||
| Gelatin | GELATIN | 2G86QN327L | SYSTEM / TOPICAL | 1050 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 14 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / ORAL | 120 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION, EMULSION / INTRAVENOUS | 0.1 %w/v | ||
| Soybean Oil | SOYBEAN OIL | 241ATL177A | SOLUTION / TOPICAL | 5.82 %w/w | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | 320 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| Corn Syrup | CORN SYRUP | 9G5L16BK6N | CAPSULE, EXTENDED RELEASE / ORAL | 28.5 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.